LAM negative (N=61) | LAM positive (N=29) | p Value | |
---|---|---|---|
Demographics | |||
Mean age, years (SD) | 37.6 (10.2) | 35.4 (7.3) | 0.25 |
Female (%) | 28 (45.9) | 16 (55.2) | 0.50 |
Clinical | |||
Mean weight, kilograms (SD) | 59.8 (10.1) | 58.6 (11.4) | 0.69 |
Mean BMI, kilograms/meter2 (SD) | 21.9 (3.4) | 21.5 (3.8) | 0.68 |
Karnofsky performance score | 0.0008 | ||
100 (%) | 43 (70.5) | 10 (34.5) | |
90 (%) | 13 (21.3) | 6 (20.7) | |
≤80 (%) | 4 (6.6) | 12 (41.4) | |
Number of tuberculosis symptoms* | 0.17 | ||
4 (%) | 48 (78.7) | 27 (93.1) | |
3 (%) | 8 (13.1) | 2 (6.9) | |
2 (%) | 5 (8.2) | 0 (0) | |
HIV testing (N=88) | |||
HIV-infected (%) | 54 (91.5) | 28 (96.6) | 0.66 |
Median CD4 count/mm3 among HIV+ (IQR) | 198 (102–270) | 106 (44–218) | 0.03 |
Tuberculosis testing by sputum induction | |||
AFB Smear Microscopy positive (%) | 8 (13.1) | 6 (20.7) | 0.39 |
Culture positive (%) | 33 (54.1) | 24 (82.8) | 0.004 |
Data are proportion of participants (%), unless otherwise indicated.
*Includes cough, fever, night sweats, weight loss.
AFB, acid-fast bacilli; BMI, body mass index (calculated as the weight in kilograms divided by the square of the height in metres); LAM, lipoarabinomannan.